Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Infinity Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (151)	3/30/2007 1:37:59 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 210

Just scanning holdings: Novartis 5.8% Amgen 7.4% Advent, something on the order of 5.5% I think. T Rowe Price 6.3% Prospect 7.28% DFA 3.38% Others are here: finance.yahoo.com I'd appreciate it if Dr. Praveen or anybody else could keep the thread updated with news releases and such. I hold only a very modest position in INFI now and I've decided to go to cash in the kid's accounts (which is why the shares dipped down today a bit). I've more than doubled the value of my kid's education IRA accounts in the last six months, and just don't feel compelled to hold stocks now. Biotech stocks have been very good to me and my family, and I appreciate all the good work that these biotech companies are doing--Infinity included. I am sure we will see great things from Infinity and thank you!